Clinical trial
Carmustine Implants in Treating Patients With Brain Metastases
NCT00003878 · New Approaches to Brain Tumor Therapy Consortium, Other · Completed
Key facts
| NCT number | NCT00003878 |
|---|---|
| Title | Carmustine Implants in Treating Patients With Brain Metastases |
| Official title | The Treatment of One or Two Supratentorial Brain Metastases With Surgical Resection and BCNU-Polymer Wafers |
| Lead sponsor | New Approaches to Brain Tumor Therapy Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Procedure |
| Interventions | polifeprosan 20 with carmustine implant, conventional surgery |
| Start date | Apr 1, 2002 |
| Completion | Apr 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: